6,678 trials
Type 2 Diabetes Mellitus
Primary: Adjusted Mean Change in HbA1c Levels — -0.55; 0.05 percentage of hemoglobin glycosylated — p=<0.0001
Inflammation · Barrett's Esophagus
Primary: Change in Inflammation Biomarker Tissue PGE2 Level — 1.35; -0.02; 1.19; -0.06 nanograms/gram of tissue — p=0.30
P Acnes Colonization
Primary: Change From Baseline in Quantitative Bacteriology Measurements at Week 4 — -1.6 log10 CFU/cm2
Acne Vulgaris
Primary: Percent Change From Baseline in Total Lesion Counts — -47; -64 Percent Change
Mitral Valve Insufficiency
Primary: Postoperative Fentanyl — 4.51; 6.14 microgram/kilogram
Constipation · Diabetes
Primary: Efficacy, Measured by the Average Number of Spontaneous Bowel Movements (SBMs) Per Week — 4.85; 1.40; 3.81; 2.41 spontaneous bowel movements
Short Stature Born Small for Gestational Age (SGA)
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 27; 31; 10; 5 participant
End Stage Renal Disease
Primary: EPO Dose — 5800; 5400; 7000; 6050 units/week — p=0.78
Pain of Anesthesia at Breast Biopsy
Primary: Pain — 1.19; 0.56 units on a scale
Elective Orthopedic Surgery
Primary: Scores on the Verbal Rating Scale For Anxiety — 1.8; 2.3; 2.8 Scores on a Scale (0-10)
Surgery · Anesthesia
Primary: Quality of Recovery Score 24 Hours Post Operative — 175; 176 units on a scale — p=0.97
Acne
Primary: Total Lesion Count — 76.7; 53.9; 50.0; 43.7 lesions
Post Menopausal Osteoporosis
Primary: Percent Change From Baseline to Month 6 in Serum C-terminal Telopeptide of Type 1 Collagen (CTX) — -55.26 percent change
Obesity
Primary: Intubation Time Using a Stop Watch — 43; 22; 45; 40 Seconds
Laminectomy
Primary: Intubation Time (Seconds) — 35; 59 Seconds